These data strongly imply the presence of a SARS-CoV-2-specific dysfunctional platelet phenotype with blunted GPIIb/IIIa activation, which is uncoupled from functional α granule release in COVID-19 patients differing from bacterial sepsis [70]. This evidence concerns the gene ITGA2B and COVID-19.